Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Core EBITDA Growth

    Back to All Ratios
MOREPEN LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -45.3620.0567.429.564.00

What is the latest Core EBITDA Growth ratio of MOREPEN LABORATORIES ?

The latest Core EBITDA Growth ratio of MOREPEN LABORATORIES is -45.36 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-45.36
Mar202220.05
Mar202167.42
Mar20209.56
Mar20194.00

How is Core EBITDA Growth of MOREPEN LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2023 -45.36
Negative
Mar2022 20.05
-70.26
Mar2021 67.42
605.23
Mar2020 9.56
139.00
Mar2019 4 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare Core EBITDA Growth ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹2,541.2 Cr -2.5% 9.3% 83.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

-2.5%

9.3%

83.4%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses